Search 33,000+ CME courses
Back

RedMedEd, Postgraduate Institute for Medicine

  • Multiple Myeloma

Exploring Recent Advances in Therapy for Patients With a First or Later Relapse of Multiple Myeloma – Activity 1

An e-learning curriculum comprising two Ace the Case microlearning activities. Each activity will feature short case presentations and quick assessments, providing information essential to achieving a specific, actionable objective relating to recent clinical advances with BCMA-targeted therapy for patients with early RRMM. Participants in these activities will be expected to improve their ability to (1) select patients who may benefit from BCMA-targeting agents for first or later relapsed myeloma setting and (2) employ strategies to mitigate AEs associated with BCMA-targeted therapy.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

ABIM — Medical KnowledgeUp to 0.25 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Included with subscription

All courses included — $249.99–299.99 / year

See plans on cliniciancareconsulting.com

Listed by the provider · cliniciancareconsulting.com

  • Microlearning
  • includes Case study / clinical scenario
  • includes Online course / module
  • Credit · Up to 0.25 credits
  • MOC · Up to 0.25 points
  • Included in subscription
  • Commercial Support
  • Released
    Mar 6, 2026
  • Last day to claim credit
    Jan 7, 2027 3 months left

Related courses

See all

Other providers’ courses on the same topic

More from Postgraduate Institute for Medicine

See all

This provider’s courses closest to this one